I. SCOPE AND METHODOLOGY
II. REPORT SYNOPSIS
1. Introduction
Bioimaging
Medical Imaging
Molecular Imaging
Radiography
X-Rays
Gamma Rays
Computational Genomics
Dynamic Imaging
Biomarker
Radiopharmacology
Imaging Modalities
Magnetic Resonance Imaging
Optical Imaging
Diffuse Optical Imaging
Tomography
Modern Tomography
History of Methods and Technologies in Bioimaging
Electron Microscope
X-Rays
Radiology and Radiography
Fluoroscopy
Functional Magnetic Resonance Imaging (fMRI)
Computational Genomics
Computed Tomography
Imaging Atom Probe
Corneal Topography
High Intensity Focused Ultrasound
Brain Machine Interface
Magnetic Resonance Imaging
Medical Ultrasonography
Neuroimaging
Optical Coherence Tomography
Optoacoustic Imaging
Positron Emission Tomography
Single-Photon Emission Computed Tomography (SPECT)
Transmission Electron Microscopy
Drug Discovery with Bioimaging
Bioimaging Agents
Segmentation of Bioimaging
Exhibit 1: Segmentation of Global Bioimaging Market by Application and Modalities
II. Global Market Analysis
Exhibit 2: Bioimaging – Global Value Market Estimations & Predictions (2005 – 2015) in US$ Billion (Graphical Representation Included)
Analysis by Application
Diagnostic
Exhibit 3: Bioimaging in Diagnostics – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Billion (Graphical Representation Included)
Exhibit 4: Bioimaging in Diagnostics – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
Research and Development
Exhibit 5: Bioimaging in Research and Development – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Billion (Graphical Representation Included)
Exhibit 6: Bioimaging in Research and Development – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
Analysis by Modalities
Ultrasound
Exhibit 7: Bioimaging by Ultrasound – Global Value Market Estimations & Predictions (2005 –2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 8: Bioimaging by Ultrasound – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
CT
Exhibit 9: Bioimaging by CT – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 10: Bioimaging by CT – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
MRI
Exhibit 11: Bioimaging by MRI – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 12: Bioimaging by MRI – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
PET
Exhibit 13: Bioimaging by PET – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 14: Bioimaging by PET – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
SPECT
Exhibit 15: Bioimaging by SPECT – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 16: Bioimaging by SPECT – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
Other
Exhibit 17: Bioimaging by Other Modalities – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) in US$ Million (Graphical Representation Included)
Exhibit 18: Bioimaging by Other Modalities – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
Exhibit 19: List of Major Global Companies
III. Regional Market Analysis
North America
Analysis by Application
Diagnostic
Exhibit 20: Bioimaging in Diagnostics – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Research and Development
Exhibit 21: Bioimaging in Research and Development – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Analysis by Modalities
Ultrasound
Exhibit 22: Bioimaging by Ultrasound – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
CT
Exhibit 23: Bioimaging by CT – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
MRI
Exhibit 24: Bioimaging by MRI – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
PET
Exhibit 25: Bioimaging by PET – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
SPECT
Exhibit 26: Bioimaging by SPECT – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Other
Exhibit 27: Bioimaging by Other Modalitites – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Europe
Analysis by Application
Diagnostic
Exhibit 28: Bioimaging in Diagnostics – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
Research and Development
Exhibit 29: Bioimaging in Research and Development – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
Analysis by Modalities
Ultrasound
Exhibit 30: Bioimaging by Ultrasound – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
CT
Exhibit 31: Bioimaging by CT – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
MRI
Exhibit 32: Bioimaging by MRI – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
PET
Exhibit 33: Bio imaging by PET – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
SPECT
Exhibit 34: Bioimaging by SPECT – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
Other
Exhibit 35: Bioimaging by Other Modalities – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
Japan
Exhibit 36: Bioimaging – Japanese Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
Asia-Pacific
Analysis by Application
Diagnostic
Exhibit 37: Bioimaging in Diagnostics – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Research and Development
Exhibit 38: Bioimaging in Research and Development – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Analysis by Modalities
Ultrasound
Exhibit 39: Bioimaging by Ultrasound – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
CT
Exhibit 40: Bioimaging by CT – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
MRI
Exhibit 41: Bioimaging by MRI – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
PET
Exhibit 42: Bioimaging by PET – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
SPECT
Exhibit 43: Bioimaging by SPECT – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Other
Exhibit 44: Bioimaging by Other Modalities – Asia-Pacific Value Market Estimations & Predictions (2005-2015) in US$ Million by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Latin America
Analysis by Application
Diagnostic
Exhibit 45: Bioimaging in Diagnostics – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Research and Development
Exhibit 46: Bioimaging in Research and Development – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Analysis by Modalities
Ultrasound
Exhibit 47: Bioimaging by Ultrasound – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
CT
Exhibit 48: Bioimaging by CT – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
MRI
Exhibit 49: Bioimaging by MRI – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
PET
Exhibit 50: Bioimaging by PET – Latin American Value Market Estimations & Predictions (2005 – 2015)by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
SPECT
Exhibit 51: Bioimaging by SPECT – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Other
Exhibit 52: Bioimaging by Other Modalities – Latin American Value Market Estimations & Predictions (2005 – 2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Rest of World
Exhibit 53: Bioimaging – Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
III. MARKET DYNAMICS
1. Market Overview
Bioimaging - A Prominent Advancement in the Field of Biomedical Research
Medical Imaging and its Prospective Role in Pharmaceutical Clinical Trials
Whole Body Imaging
2. Global Market Analysis
Exhibit 54: Bioimaging – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World in US$ Billion (Graphical Representation Included)
Exhibit 55: Bioimaging – Global Value Market Shares (2009 & 2015) by Geographic Region for North America, Europe, Japan, Asia-Pacific, Latin America and Rest of World (RoW) (Graphical Representation Included)
Market Analysis by Segmentation
Analysis by Application
Exhibit 56: Bioimaging – Global Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Billion (Graphical Representation Included)
Exhibit 57: Bioimaging – Global Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 58: Bioimaging – Global Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Billion (Graphical Representation Included)
Exhibit 59: Bioimaging – Global Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
3. Market Trends
Focus of Bioimaging
Future of Bioimaging
Bioimaging - Present and Future
Less Invasive Mammography
Looking into the Brain
Pocket – size Ultrasound
4. Major Global Companies In Bioimaging Industry
Advanced Research Technologies, Inc. (Canada)
Analogic Corporation (USA)
Bayer HealthCare Pharmaceuticals (Germany)
Bracco SpA (Italy)
Carestream Health, Inc. (USA)
More…
5. Major Activities in Bioimaging Industry
TechniScan Signs Agreement Womens3D to Co-Develop Latest Breast Imaging Device
Nordion Extends Molybdenum-99 Supply Contract with Lantheus Medical Imaging to Provide Medical Isotope Update
Eli Lilly Acquires Avid Radiopharmaceuticals
National Guard Health Affairs of Saudi Arabia Enters Agreement with IMRIS and Varian
Creaform Acquires Engineering Services Provider – Genicad
Hologic Signs Partnership Agreement with SuperSonic Imagine
Biospace Med Changes its Name to EOS Imaging
FEI and Nanonics Collaborate for Hybrid AFM/Dualbeam System
Carestream Health Takes Over Quantum Medical Imaging
Roche Puchases Biolmagene
Hologic Acquires Sentinelle Medical
Olympus’ Subsidiary Acquires Innov-X Systems Inc
More……
6. Major Product Innovations/Launches in Bioimaging Industry
Applied Precision Launches New Products in DeltaVision Microscopy Product Line
LI-COR Introduces New Odysseyฎ Sa Infrared Imaging System
Hologic Receives FDA Approval for Selenia Dimensions (3-D) Digital
Mindray Upgrades M7 and DC-7 Ultrasound Platforms
Hamamatsu Develops Auto-Gating Feature for Image Intensifiers to Enable High-SensitivityImaging at All Hours
Bayer Launches Betaferonฎ in China
Philips Introduces iU22 xMATRIX Ultrasound System
Analogic's BK Medical Subsidiary Introduces Flex Focus 700
TomTec Introduces 4D MV-Assessment
Riverain Medical’s SoftView Technology of Digital Radiograghy Systems from Siemens
Merge Healthcare Launches Latest Clinical Trial Imaging Solution
Philips Launches Allura Xper Interventional X-Ray System
More……
7. Regional Market Analysis
A. NORTH AMERICA
Exhibit 60: Bioimaging – North American Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
Exhibit 61: List of Major Companies In North America
Analysis by Country
Exhibit 62: Bioimaging – North American Value Market Estimations & Predictions (2005 – 2015) by Country for the United States and Canada in US$ Million (Graphical Representation Included)
Exhibit 63: Bioimaging – North American Value Market Shares (2009 & 2015) by Country for the United States and Canada (Graphical Representation Included)
Analysis by Application
Exhibit 64: Bioimaging – North American Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Exhibit 65: Bioimaging – North American Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 66: Bioimaging – North American Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 67: Bioimaging – North American Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
A1. United States
Analysis by Application
Exhibit 68: Bioimaging – United States Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 69: Bioimaging – United States Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
A2. Canada
Analysis by Application
Exhibit 70: Bioimaging – Canadian Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 71: Bioimaging – Canadian Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
B. EUROPE
Exhibit 72: Bioimaging – European Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
Exhibit 73: List of Major Companies In Europe
Analysis by Country
Exhibit 74: Bioimaging – European Value Market Estimations & Predictions (2005 – 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe in US$ Million (Graphical Representation Included)
Exhibit 75: Bioimaging – European Value Market Shares (2009 & 2015) by Country for Germany, United Kingdom, France, Italy and Rest of Europe (Graphical Representation Included)
Analysis by Application
Exhibit 76: Bioimaging – European Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Exhibit 77: Bioimaging – European Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 78: Bioimaging – European Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 79: Bioimaging – European Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
B1. Germany
Analysis by Application
Exhibit 80: Bioimaging – German Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 81: Bioimaging – German Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
B2. United Kingdom
Analysis by Application
Exhibit 82: Bioimaging – United Kingdom Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 83: Bioimaging – United Kingdom Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
B3. France
Analysis by Application
Exhibit 84: Bioimaging – French Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 85: Bioimaging – French Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
B4. Italy
Analysis by Application
Exhibit 86: Bioimaging – Italian Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 87: Bioimaging – Italian Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
B5. Rest of Europe
Analysis by Application
Exhibit 88: Bioimaging – Rest of Europe Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 89: Bioimaging – Rest of Europe Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
C. JAPAN
Exhibit 90: Bioimaging – Japanese Value Market Estimations & Predictions (2005 – 2015) in US$ Million (Graphical Representation Included)
Exhibit 91: List of Major Companies In Japan
Analysis by Application
Exhibit 92: Bioimaging – Japanese Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Exhibit 93: Bioimaging – Japanese Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 94: Bioimaging – Japanese Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 95: Bioimaging – Japanese Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
D. ASIA-PACIFIC
Exhibit 96: Bioimaging – Asia-Pacific Value Market Estimations & Predictions (2005 – 2015) in US$ Million (Graphical Representation Included)
Exhibit 97: List of Major Companies In Asia-Pacific
Analysis by Country
Exhibit 98: Bioimaging – Asia-Pacific Value Market Estimations & Predictions (2005 – 2015) by Country for Australia, China, India and Rest of Asia-Pacific in US$ Million (Graphical Representation Included)
Exhibit 99: Bioimaging – Asia-Pacific Value Market Shares (2009 & 2015) by Country for Australia, China, India and Rest of Asia-Pacific (Graphical Representation Included)
Analysis by Application
Exhibit 100: Bioimaging – Asia-Pacific Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Exhibit 101: Bioimaging – Asia-Pacific Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 102: Bioimaging – Asia-Pacific Value Market Estimations & Predictions (2005 –2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 103: Bioimaging – Asia-Pacific Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
D1. Australia
Analysis by Application
Exhibit 104: Bioimaging – Australian Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 105: Bioimaging – Australian Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
D2. China
Analysis by Application
Exhibit 106: Bioimaging – Chinese Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 107: Bioimaging – Chinese Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
D3. India
Analysis by Application
Exhibit 108: Bioimaging – Indian Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 109: Bioimaging – Indian Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
D4. Rest of Asia-Pacific
Analysis by Application
Exhibit 110: Bioimaging – Rest of Asia-Pacific Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 111: Bioimaging – Rest of Asia-Pacific Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
E. LATIN AMERICA
Exhibit 112: Bioimaging – Latin America Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
Analysis by Country
Exhibit 113: Bioimaging – Bioimaging – Latin America Value Market Estimations & Predictions (2005-2015) by Country for Brazil, Mexico and Rest of Latin America in US$ Million (Graphical Representation Included)
Exhibit 114: Bioimaging – Latin American Value Market Shares (2009 & 2015) by Country for Brazil, Mexico and Rest of Latin America (Graphical Representation Included)
Analysis by Application
Exhibit 115: Bioimaging – Latin American Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Exhibit 116: Bioimaging – Latin American Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 117: Bioimaging – Latin American Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 118: Bioimaging – Latin American Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
E2. Brazil
Analysis by Application
Exhibit 119: Bioimaging – Brazilian Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 120: Bioimaging – Brazilian Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
E3. Mexico
Analysis by Application
Exhibit 121: Bioimaging – Mexican Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 122: Bioimaging – Mexican Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
E4. Rest of Latin America
Analysis by Application
Exhibit 123: Bioimaging – Rest of Latin America Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included)
Analysis by Modalities
Exhibit 124: Bioimaging – Rest of Latin America Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
F. REST OF WORLD
Exhibit 125: Bioimaging – Rest of World Value Market Estimations & Predictions (2005-2015) in US$ Million (Graphical Representation Included)
Analysis by Application
Exhibit 126: Bioimaging – Rest of World Value Market Estimations & Predictions (2005 – 2015) by Application for Diagnostics and Research and Development in US$ Million (Graphical Representation Included
Exhibit 127: Bioimaging – Rest of World Value Market Shares (2009 & 2015) by Application for Diagnostics and Research and Development (Graphical Representation Included)
Analysis by Modalities
Exhibit 128: Bioimaging – Rest of World Value Market Estimations & Predictions (2005 – 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other in US$ Million (Graphical Representation Included)
Exhibit 129: Bioimaging – Rest of World Value Market Shares (2009 & 2015) by Modalities for Ultrasound, CT, MRI, PET, SPECT and Other (Graphical Representation Included)
IV. PRODUCT TECHNOLOGY/RESEARCH
1.Introduction
Imaging Techniques
Imaging Techniques in Drug Development
Digital Imaging
Digital Image Processing
1. Image
2. Digital Images
3. Digital Image Processing Systems
4. Analog vs. Digital Images
5. Converting from Analog Image to Digital Image
6. Color and Grayscale Images
7. Digital Image Processing (DIP) System
8. Digital Image Processing Steps
Principles of Diagnostic Imaging Tools
1. Magnetic Resonance Imaging
A. Single Photon Emission Computed Tomography
B. Computed Tomography
The Present Day Imaging Technology
Fluoroscopy Techniques
Structure and Set Up of Initial Fluoroscope Design
X-Ray Image Intensifiers: An Apparatus to View Images under Normal Light
Flat-Panel Detectors: A Replacement for Image Intensifiers
Medical Imaging
Medical Imaging Fluoroscopy – Advantages
Molecular Imaging
Enhancements in Cancer through Molecular Imaging
The Functionality of Operational Molecular Imaging in Cancer
Role of PET in Molecular Imaging in Relation to Cancer
Molecular Imaging Usage in Improvising Cancer Therapeutics
Application of Molecular Imaging in Chemotherapy
Molecular Imaging in Neurology
PET based Molecular Imaging for Neurological Ailments
Prospects for Molecular Neuroimaging
Diagnostic
Molecular Imaging of the Lungs
Molecular Imaging of Musculoskeletal Diseases
Molecular Imaging of the Kidneys with PET
Molecular Imaging of Antiangiogenic Agents
Craniofacial Scanning
Chest Scanning
Cardiac Scanning
Abdominal Scanning
Pelvis Scanning
Research and Development
Functional Imaging in Drug Discovery and Development
Role of Imaging Biomarkers in the Discovery and Development of Cancer Drugs
Advantages of Biomarkers
Reporter Mice and Drug Discovery and Development
The Potential of High-Content High-Throughput Microscopy in Drug Discovery
Noninvasive Imaging of Melanoma with Reflectance Mode Confocal Scanning Laser Microscopy
Dynamic Imaging of Chemokine-Dependent CD8+ T cell Help for CD8+ T cell Responses
Functional Genomics and Radioisotope-Based Imaging Procedures
Imaging and Oncologic Drug Development
The Role of Bioimaging in Drug Discovery
Clinical Biomarkers in Drug Discovery and Development
Using Imaging Biomarkers to Accelerate Drug Development and Clinical Trials
Pharmacodynamic Biomarkers for Molecular Cancer Therapeutics
Development and Use of Biomarkers in Oncology Drug Development
Biomedical /Medico Related Benefits in R&D via Biomarkers
Right Parietal Dysfunction in Children with Attention Deficit Hyperactivity Disorder,
Combined Type A Functional MRI Study
Molecular, Cellular and Functional Imaging of Atherothrombosis
Quantum Dots: Superior Alternative in Bioimaging Technology
2. Segmentation by Modalities
Ultrasound
Ultrasound – Types
3D Ultrasound
Ultrasonography
Modes of Sonography
Doppler Sonography
Strengths of Sonography
Medical Ultrasonography
Healing Sound: The Use of Ultrasound in Drug Delivery and Other Therapeutic Applications
Application of Intravascular Ultrasound in Anti-Atherosclerotic Drug Development
High Intensity Focused Ultrasound (HIFU) - Technology for Treatment of Cancer
Use of High Concentration Ultrasound Beams
CT
Computed Tomography
Tomosynthesis
Types of Acquisition
i. Scout/Pilot/Tomogram
ii. Axial
iii. Cine
iv. Helical
v. DRR
vi. Generations
vii. Electron Beam CT
viii. Helical or Spiral CT
xi. Multislice CT
x. Dual Source CT
xi. 256 Slice CT
xii. Inverse Geometry CT
xiii. 3D Rendering Techniques
MRI
Magnetic Resonance Imaging (MRI): The Latest Advancements in the Imaging Technology
i. Diffusion Magnetic Resonance Imaging
ii. Magnetic Resonance Angiography
iii. Magnetic Resonance Spectroscopy
iv. Functional Magnetic Resonance Imaging
Magnetic Resonance Imaging and its Advantage over Conventional X-Ray and CT Scans
Primary Aim of fMRI Data Analysis
The Available Varieties of Sophisticated MRI Scans
Diffusion Magnetic Resonance Imaging: An Effective way of Measuring Water Molecules in Biological Tissues
Magnetic Resonance Angiography: A Method for Analyzing Arteries
Magnetic Resonance Spectroscopy: A Combination of NMR Spectroscopy and Spatially Addressable MRI
Functional Magnetic Resonance Imaging: An Indicator of Brain’s Neural Activity
Interventional MRI
Radiation Therapy Simulation: An Effective Method for Location of Tumors
Current Density Imaging: Works on Principle of Generation of Magnetic Field
Magnetic Resonance Guided Focused Ultrasound
Multinuclear Imaging to aid Functional Imaging
Multi-Mode Imaging System and its Application to Achieve Thermal Ablation
Role of fMRI in Optimizing CNS Drug Development
Nuclear Medicine Imaging: A Novel Means of Drug Discovery in Gene Therapy
Diagnostic Testing
Types of Radionuclides
Imaging Equipment
Analysis
Radionuclide Imaging in Drug Development
Receptor Imaging in Oncology by Means of Nuclear Medicine
Nuclear Medicine Studies of the Prostate, Testes and Bladder
In Vivo Imaging of Oligonucleotides with Nuclear Tomography
Molecular Imaging in Evaluation of In Vivo Behavior of Drugs
Nuclear Imaging Methods for Non-Invasive Drug Monitoring
Biomedical Imaging in Pharmacology with Nuclear Medical Imaging Methodologies
Nuclear Medicine Radiopharmaceuticals
PET
Positron Emission Tomography
Application of PET Scanning in Medicine and Research
Applications in Drug Discovery and Drug Development
Role of PET in Pharmacokinetic Analysis
Pharmacokinetic Imaging: A Non-invasive Method for Determining Drug Distribution and Action
Positron Emission Tomography Implications in the Advancement of Molecular aimed Cancer Curatives
Functional PET Imaging in Anti-Cancer Drug Development
Using PET to Facilitate CNS Drug Development
Pharmacokinetic Considerations in the PET and SPECT Evaluation of CNS Receptors
PET for In Vivo Pharmacokinetic and Pharmacodynamic Measurements
Psychotropic Drug Development using PET
PET and SPECT Imaging of the Opioid System: Receptors, Radioligands
PET in Treatment of Movement Disorders
Application of PET Scans in the Field of Oncology
PET Neuroimaging Scan to Analyze Activities of the Human Brain
Application of PET Scan in Neuropsychology and Cognitive Neuroscience
Application of PET Imaging in Treatment of Pediatric Hodgkin's Lymphoma
Potential Application of PET/CT Imaging in the Treatment of Lung Cancer
Radio Isotope Compounds Utilized in PET Scanning
SPECT
Applications of Single Photon Emission Computed Tomography (SPECT)
Other Modalitites
Projection Radiography
Mammography
Dental Radiography
Digital Radiography
Other Detection Devices
Geiger Counter
Scintillators
Fluoroscopy
Energy Dispersive X-Ray Spectroscopy
Electron Microscopes for Bioimaging
a. Scanning Electron Microscope (SEM)
b. Transmission Electron Microscope (TEM)
c. Scanning Transmission Electron Microscopy (STEM)
d. Reflection Electron Microscope (REM)
Bioimaging Procedures being used or Developed for Generating 3D Images
a. Diffuse Optical Tomography (DOT) or Diffuse Optical Imaging (DOI)
b. Elastography
c. Electrical Impedance Tomography
d. Optoacoustic Imaging
e. Ophthalmology
A-Scan Ultrasound Biometry
B-Scan Ultrasonography
C-Scan Ultrasonography
f. Corneal Topography
g. Optical Coherence Tomography
h. Scanning Laser Ophthalmoscopy
Types of Tomography
Based on Movement
i. Linear Tomography
ii. Poly Tomography
iii. Zonography
iv. Orthopantomography
v. Computed Tomography
vi. Tomosynthesis
vii. Electron Beam CT
viii. Helical or Spiral CT
ix. Multislice CT
x. 256 Slice CT
xii. Inverse Geometry CT
xiii. 3D Rendering Techniques
Based on Principle of Working
a. Confocal Laser Scanning Microscopy
b. Cryo-Electron Tomography
c. Magnetic Induction Tomography
d. Process Tomography
e. Photoacoustic Tomography
f. Single Photon Emission Computed Tomography
g. X-ray Tomography
h. Positron Emission Tomography
i. Optical Coherence Tomography
Single Point Optical Coherence Tomography
Parallel Optical Coherence Tomography
Fluorescence Lifetime Imaging
Gallium Imaging
Optoacoustic Imaging
Photoacoustic Imaging
Diffusion-Weighted Imaging
Bioluminescence Imaging
Calcium Imaging
Diagnostic Imaging Agents
A. Reagents
B. Contrast agents
Exhibit 130: Imaging Agents – Global Value Market Estimations & Predictions (2005 – 2015) by Geographic Region for the North America, Japan, Europe and Rest of World in US$ Billion (Graphical Representation Included)
Exhibit 131: Imaging Agents – Global Value Market Shares (2009 & 2015) by Geographic Region for the North America, Japan, Europe and Rest of World (Graphical Representation Included)
Exhibit 132: Therapeutic and Diagnostic Imaging Antibodies – Global Value Market Estimations & Predictions (2005 – 2015) in US$ Billion (Graphical Representation Included)
Neuroimaging
Basics of Brain Imaging
Computed Axial Tomography
Magnetic Resonance Imaging
Working of MRI
Functional Magnetic Resonance Imaging
fMRI Technique: Mixture of Technical and Medical Fields
Advantages of fMRI
Other Techniques
Contrast MR
Arterial Spin Labeling
Magnetic Resonance Spectroscopic Imaging
Diffusion Tensor Imaging
Positro Emission Tomography
Molecular Neuroimaging
Latest Technologies in Neuroimaging
Radioactivity and Brain Imaging
Multimodal Neuroimaging
Functional Brain Imaging
Neuroimaging for Neuropsychiatry
Diagnosing and Treating Neuroendocrine Tumors
Neuropharmacology and Drug Development
Spontaneous Fluctuations in Brain Activity Observed with Functional Magnetic Resonance Imaging
Role of Neuroimaging in Alzheimer's Disease, with Emphasis on Brain Perfusion SPECT
Treatment for Behavioural Disorders in Neurodegenerative Diseases:
Drug Development Strategies
Computational Bioimaging
Bioimaging Software
A. Mimics3D Application Deliverables
B. Analysis of Functional Neuro Images
C. Neuro Imaging Application
D. SAS (Ictal-Interictal SPECT Assay by SPM)
Neuroimaging Software
Digital Signal Processing (DSP)
Optimization and Advantages of FPGA
Standardized Digital Photography in Medicine
Consistent Photo Documentation for Clinical Trials
Biosoftware Dermoscope
Grid-based Computer-Aided Detection System (Grid CAD)
Computational Genomics Research – Advantages
Intervention Magnetic Character Imaging
Radiation Cure Reproduction
Current Density Imaging
High Powered Magnetic Character Concentrated Ultrasound Function
1. High Intensity Focused Ultrasound
2. Functionality of High Intensity Focused Ultrasound
Multinucleate Imaging
Anlytical Magnetic Character Imaging Techniques
Interpretation and Interpolation of Data using Imaging
Hurdles Encountered During Imaging
3. Research Briefs
Compression ultrasound for DVT
CT Scan for Abdominal Pain
Elastography for Breast Cancer
Ultrasound Methodology for Ovarian Cancer
Merging SPECT-CT images in Breast Cancer Treatment
XFEL for Membrane Protein Structure
Urological Study Showed Stereotactic Biopsy System Delivered Greater Accuracy in Detecting Cancer and Planning for Targeted Prostate Cancer Therapies
Targeted Prostate Cancer Biopsy and Cancer Treatment Has Been Accepted by Nation’s
4. Bioimaging – The Outlook
V. CORPORATE DIRECTORY
VI. PATENTS INFORMATION